Dear Subscriber,
2020 has been a year none of us will forget, bringing changes we could not have imagined.
At the same time we’ve seen the power of what science can do when faced with such a global challenge. Proteomics has had a key part to play in tackling COVID-19, for example in the identification of potential drug targets and understanding the immune response to the disease.
Beyond the pandemic, we’ve seen a step change in our tools and technologies over the past 12 months, firmly establishing proteomics as a precision science with applications across the entire research pipeline.
From advances in instrumentation and automation to combining machine learning with user-friendly analytical software, read our CTO Lukas Reiter’s LinkedIn article to find out how progress in proteomics is bringing a new era of discovery for the life sciences.
